Legal & General Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Legal & General Group’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,641	Closed	-$24K	–	3722
2021 Q1	$24K	Buy	4,641 +2,581	+125%	+$13.4K	﹤0.01%	3065
2020 Q4	$8K	Hold	2,060	–	–	﹤0.01%	3403
2020 Q3	$10K	Sell	2,060 -892	-30%	-$4.87K	﹤0.01%	3243
2020 Q2	$16K	Buy	+2,952	New	+$13.5K	﹤0.01%	3167
2017 Q2	–	Sell	-4,514	Closed	-$31K	–	3402
2017 Q1	$31K	Hold	4,514	–	–	﹤0.01%	2971
2016 Q4	$43K	Buy	4,514 +2,232	+98%	+$20.1K	﹤0.01%	2925
2016 Q3	$22K	Hold	2,282	–	–	﹤0.01%	2800
2016 Q2	$32K	Buy	+2,282	New	+$35.6K	﹤0.01%	2703

Other funds holding AGTC

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Legal & General Group's AGTC Position: Q2 2021 in Review

Legal & General Group sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2021, closing a stake of 4,641 shares — an estimated $24K sold.

Legal & General Group first reported a position in AGTC in Q2 2016 and held it in 8 quarters. The position peaked at $43K in Q4 2016. 71 funds tracked by Wall St. Rank hold AGTC as of Q2 2021.

Legal & General Group reported no remaining Applied Genetic Technologies Corporation position as of Q2 2021 after selling out during the quarter.
Legal & General Group sold 4,641 Applied Genetic Technologies Corporation shares in Q2 2021, an estimated $24K.
Legal & General Group first reported a position in Applied Genetic Technologies Corporation in Q2 2016 and held it in 8 quarters.
Legal & General Group's Applied Genetic Technologies Corporation position peaked at $43K in Q4 2016.
71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.